AH Apotex Health Corp. Stock: price and management transactions · Canada · SEDISource id SEDI:apotex-health-corp CA · SEDI Follow the Apotex Health Corp. stock price and the full management transaction log of the company, a publicly traded company based in Canada. Shares trade on the CA market, under the supervision of SEDI. The latest transaction was reported on 19 August 2026 (56 - Grant of rights). Among the most active insiders: Watson, Jeff. All data is accessible without an account.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 August 2026
All Executives83 Thresholds0 Prospectus0 Other0
Declarations 83 total
● 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 13 Aug 2026
136,158 shares Restricted Share Units SEDI:4766174 ● 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
112,682 shares Restricted Share Units SEDI:4766171 ◇ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
338,046 shares Options SEDI:4766170 ● 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
9,557 shares Restricted Share Units SEDI:4766169 ◇ 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
28,671 shares Options SEDI:4766167 ● 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
12,228 shares Restricted Share Units SEDI:4766166 ◇ 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
36,684 shares Options SEDI:4766165 ● 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
12,406 shares Restricted Share Units SEDI:4766162 ◇ 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
37,218 shares Options SEDI:4766160 ● 4 - Director of Issuer · Executives · 1 Jul 2026
5,828 shares Deferred Share Units SEDI:4766159 ● 4 - Director of Issuer · Executives · 9 Jun 2026
Deferred Share Units SEDI:4766158 ● 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
20,205 shares Restricted Share Units SEDI:4766157 ◇ 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
60,615 shares Options SEDI:4766154 ● 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
12,840 shares Restricted Share Units SEDI:4766118 ◇ 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
38,520 shares Options SEDI:4766117 ● 5 - Senior Officer of Issuer · Executives · 9 Jun 2026
● 4 - Director of Issuer · Executives · 1 Jul 2026
3,846 shares Deferred Share Units SEDI:4766114 ● 4 - Director of Issuer · Executives · 9 Jun 2026
Deferred Share Units SEDI:4766113 ● 4 - Director of Issuer · Executives · 1 Jul 2026
3,846 shares Deferred Share Units SEDI:4766112 ● 4 - Director of Issuer · Executives · 9 Jun 2026
Deferred Share Units SEDI:4766111 ● 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
4,429 shares Restricted Share Units SEDI:4766109 ● 5 - Senior Officer of Issuer · Executives · 9 Jun 2026
Restricted Share Units SEDI:4766107 ◇ 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
13,287 shares Options SEDI:4766106 ● 5 - Senior Officer of Issuer · Executives · 9 Jun 2026
● 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
12,228 shares Restricted Share Units SEDI:4766104 25 of 83 declarations
Load more (58 remaining) 关于 Apotex Health Corp. Apotex Health Corp. 是一家加拿大制药公司，专门从事仿制药的生产。该公司在多伦多证券交易所上市，股票代码为XTSE。